科力爾(002892.SZ):全資孫公司擬與瑞業數金共同組建圍繞電機相關產業的私募股權基金平台
格隆匯12月25日丨科力爾(002892.SZ)公佈,2023年12月25日,科力爾電機集團股份有限公司的全資孫公司深圳市鵬睿投資發展有限公司與深圳市瑞業數金資產管理有限公司(簡稱“瑞業數金”)簽訂了《戰略合作協議》。雙方擬通過多元的渠道和資源整合,共同組建圍繞電機相關產業的私募股權基金平台。
雙方可共同引進地方政府平台、市場化母基金等機構投資人組建股權投資基金,藉助雙方資源優勢和技術平台,通過投資電機、驅控系統行業及其產業鏈上下游的企業助力公司技術轉型升級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.